chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mom noticed a bump on the left thigh at the site of vaccination, erythematous, urticarial 2 cm by half cm with some induration and tenderness.  Mom was advised to use 12.5 mg/5ml one teaspoon every eight hours for 3 days.
Had weird tingling on RIGHT side of body evening of 1st shot.  Had a strangle pounding heart episode in the middle of the night, lasted maybe 2-minutes. Woke up morning after with shingles on RIGHT side of body, increasing pain. Called Hospital (where my 1st dose was given) and they referred me to their urgent care (facility listed in this report). I went, was diagnosed with shingles & put on antivirals & a nerve blocker. Went away pretty quick with antivirals, never took the nerve blocker.  Continued to have occasional pounding heart episodes. Seems to occur when I am resting/sleeping. After a rather intense/longer lasting one, I went to the ER to see what was going on. No episode occurred while I was there. The episodes started being further & further apart.   Continued to have a
11 hours after injection SHAKING CHILLS, teeth chattering to the extreme. 101.5 fever throughout the night. Fatigue
headache; This is a spontaneous report from a contactable other hcp (patient). This report was received via a sales representative. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date in Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Apr2021, the patient experienced headache. It was reported that after shot 1 the patient experienced headache that would come and go and after shot 2 the patient also experienced a headache that would come and go and a little bit of chest pain after the second shot. It was reported that she received both shots in April 2021. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine given SQ left lateral inferior arm, 10cmx 7 cm redness, induration 4x4cm. Tx to include Benadryl , warm pack and f/u 1-12-06 in clinic for re-eval.
As a result of the Covid vaccine activating my immune system against the Covid virus, my immune system was also activated to create a bad flare up of my autoimmune disease, Pemphigus Vulgaris. I developed very bad oozing blisters on my scalp. I also had a couple of blisters on my shoulder, chest, and back. In order to quiet down my immune system, my dermatologist put me on Prednisone for 10 days (6 days of 40 MG and 4 days of 20 MG). My skin  has improved but is not entirely healed. I will also need to see a rheumatologist in July.
3 DAY LOW FEVER 11/30/10 TO 12/3/10 3 DAYS SEVERE ITCHING ON THE OUTSIDE OF THE THIGHS, AND OUTSIDE OF THE ARMS FROM 12/5/10 TO 12/7/10. NOW FROM 12/8/10 HIVES ON THE RIGHT UPPER THIGH.  I WILL TRY BENADRYL.
Patient is a 86 year old Male who is being admitted on 9/27/2021 chief complaint of weakness.  Patient with hx CKD 3, HTN, HLD, prostate CA, CAD with PCI, COPD, gout, diabetic neuropathy who came for for slurring speech and near syncope post vaccine booster shot and now with AKI, negative MI.  Daughter also reported poor appetite recently
Expired Havrix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 52-year-old female patient who received HAV (Havrix) (batch number H4H53, expiry date 30th January 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th February 2023, the patient received Havrix and Havrix Pre-Filled Syringe Device. On 9th February 2023, unknown after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 20-Feb-2023 Reporter's comment: The reporter did not consent to follow-up. Additional supportive information: The patient received an expired dose of Havrix, which led to expired vaccine used.
Pt states she feels dizzy and weak. Pt states she has been fasting and hasn?t had anything to eat. Pt was moved to exam area. Pts vitals are stable. Pt was given an apple to eat. Pt states she is feeling better and wants to leave. Pt didn?t require transport to hospital
This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her both arms and both legs) and VACCINATION SITE RASH (Rash at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On 10-Mar-2021, the patient experienced RASH (Rash on her both arms and both legs). On 01-Mar-2021, VACCINATION SITE RASH (Rash at injection site) had resolved. At the time of the report, RASH (Rash on her both arms and both legs) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Updated action taken, re-challenge .
9/7/22- current: Large decrease in milk production 9/13/22:Mastitis L breast- antibiotics prescribed by lactation provider 9/30/22: Mastitis R breast- antibiotics prescribed and see in ED
Redness and increased edema to deltoid of right arm. 9 cm X 9 cm area. Warm to touch. Recommend cool wash cloth or cool pack to area- elevate arm at rest and take po ibuprofen every 4-6 hrs for pain and inflammation.
5-7 minutes after vaccine patient started complaining of abdominal "fullness" and being lightheaded.  Patient cleared by EMS and provided instruction on what to do if any further symptoms including v-safe reporting.
Day 5 of Moderate to severe bilateral hand and wrist pain following Pfizer 1st COVID-19 injection 0n 02/21/21.  Unable to prepare meals, wash dishes, do laundry or other daily chores.  My son is typing this message for me.  At this time I do not plan to get the second injection.  Am sending this message to the CDC and Pfizer.  Two 650MG Tylenol gives me little relief.  I'm hopeful that someone might suggest something else.
3 days after he received PNEUMOVAX 23 and AFLURIA QUAD arm became red, swollen, itch, bumpy and the Band-Aid has left a blistering mark. Pt was admitted to urgent care and was prescribed KEFLEX 500g TID x 7D and hydrocortisone 0.5% cream BID x 7D.
Janssen 3/8/21, Pfizer 11/8/21. Positive on 7/5/22
no adverse effects reported; the patient received an improperly stored dose of VARIVAX; This spontaneous report as received from a nurse refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 10-OCT-2019, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot # S005078, expiration date 19-FEB-2019, for prophylaxis (dose, frequency and route of administration were not provided), which was reconstituted with a sterile diluent (lot #, expiration date and route of administration were not provided). The vaccine was exposed to a temperature of -14 degrees Celsius for 45 minutes and -9 to 8 degrees Celsius for 75 minutes. There were no previous temperature excursion. The call was made because of digital data logger. There were no adverse effects reported. The outcome of product storage error and no adverse event was unknown.
fever approx 8 hrs p/vax followed by sz w/1 prior febrile sz;
Myalgia & Fever Narrative: Employee reports symptoms of injection site pain/discomfort, chills, fever, body aches, scratchy throat, runny nose, and decreased appetite which began an hour after receiving vaccine and extended for ~2days. Reports used Aleve for symptom relief. No other information provided.
approx 3yrs p/vax pt presented w/mild case of chickenpox that appeared to be a variant of chickenpox, pt was afebrile
Generalized weakness and fatigue. Dry cough and nausea. Light headedness Troponins elevated, pt in afib with rvr and pleural effusion
Information has been received from a nurse practitioner concerning a female who on 02-JUL-2008 was vaccinated with GARDASIL vaccine (yeast) 0.5 mL intramuscularly in the deltoid. On 02-JUL-2008, the patient experienced "hive like area near the injection site" after receiving the dose of GARDASIL vaccine (yeast). The patient sought treatment for adverse symptoms with an unspecified family physician. The patient was prescribed BENADRYL and cortisone cream. The symptoms resolved in "about one week". No other symptoms or treatment reported. Additional information has been requested.
This spontaneous report as received from a nurse practitioner referring to a male patient of unknown age who on an unknown date, was vaccinated with a second dose of GARDASIL (dose, route of administration and lot not reported). The nurse practitioner reported that a male patient developed a fever following the second dose of GARDASIL. The nurse practitioner reported that the male patient developed a fever of 103.5 shortly after administration of the second dose of GARDASIL (time frame development of the fever was unspecified). The fever after administration of the second dose of GARDASIL was unresponsive to Ibuprofen and TYLENOL. The fever after administration of the second dose of GARDASIL lasted for 24 hours and then resolved. Dates of administration of the first and second dose of GARDASIL were not available at the time of the call (dates unspecified). Additional information is not expected.
A circular red patch, a little itchy, little swelling; A circular red patch, a little itchy, little swelling; A circular red patch, a little itchy, little swelling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (A circular red patch, a little itchy, little swelling), RASH PRURITIC (A circular red patch, a little itchy, little swelling) and RASH (A circular red patch, a little itchy, little swelling) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01262CA) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced SWELLING (A circular red patch, a little itchy, little swelling), RASH PRURITIC (A circular red patch, a little itchy, little swelling) and RASH (A circular red patch, a little itchy, little swelling). On 08-Feb-2021, SWELLING (A circular red patch, a little itchy, little swelling), RASH PRURITIC (A circular red patch, a little itchy, little swelling) and RASH (A circular red patch, a little itchy, little swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Customer was walking out of store with father when he stated to Dad that he was felling lightheaded, dizzy, and had blurred vision. Customer passed out. Father caught son and helped him to the ground.  Father came back to get pharmacist. Upon arriving to the customer, patient was alert but was very lightheaded and nausea.  No anaphylactic reaction observed.  Helped customer sit up but was nauseated.  Customer vomited twice.  Gave customer water, orange juice and cookies to help with nausea.
recurrent headaches; right eye pain; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2 (BNT162B2), on 19Mar2022 at 17:00 as dose 3 (booster), single (Lot number: FK9896) at the age of 41 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: CARVEDILOL. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: 30130BA, Location of injection: Arm Right, Vaccine Administration Time: 05:00 PM), administration date: 22Sep2021, when the patient was 40-year-old, for COVID-19 immunization, reaction(s): "Inappropriate schedule of vaccine administered", "Headache", "right eye pain"; BNT162b2 (Dose Number: 1, Batch/Lot No: FC3182, Location of injection: Arm Right, Vaccine Administration Time: 05:00 PM, Headaches within days of receiving first dose 21Sep2021 and recurrent headaches/Most days out of the week with headaches, most hours of the day with headaches), administration date: 21Sep2021, when the patient was 40-year-old, for COVID-19 immunization, reaction(s): "Headache", "right eye pain". The following information was reported: HEADACHE (non-serious) with onset 2022, outcome "not recovered", described as "recurrent headaches"; EYE PAIN (non-serious) with onset 2022, outcome "not recovered", described as "right eye pain". The events "recurrent headaches" and "right eye pain" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, eye pain.  Additional information: The facility type of vaccine was reported as pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient had no known allergies. The patient received Carvedilol 12.5mg within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and patient has been tested for COVID-19, since the vaccination. Reported that, Headaches within days of receiving first dose 21Sep2021, and recurrent headaches, right eye pain ever since until this very day. Most days out of the week with headaches, most hours of the day with headaches, NEVER had a history of headaches. Headaches started after Pfizer vaccine and led patient to go to Ophthalmologist and have MRI performed on brain. Patient stated, this vaccine is UNSAFE. The patient receiving the treatment with MRI, DAILY MEDs for Headache PAIN.; Sender's Comments: Linked Report(s) : Same patient/vaccine/event, different vaccine dose;
11/20: PT DEVELOPED HA AND VOMITING ABOUT 1 HR AFTER SHOTS THEN GOT SORE MUSCLES 12/6: FIRST SPOT NOTED 12/8: PT HAVING DIFFICULTY USING HANDS DUE TO PAINFUL STIFFNESS.  PT C/O NIGHT SWEATS, SORE MUSCLES, NOW BREAKING OUT W/SPOTS, ITCHY AND PAINFUL.  TROUBLE SWALLOWING 2ND TO PAIN.  NO DIARRHEA.  URINE NL.  EYES ITCHY AND BLURRY.  COUGH FOR SEVERAL MONTHS - HURTS TO COUGH.  USING APAP AND IBUPROFEN AT HOME - MOSTLY APAP AT NL DOSES. RANITIDINE 150 MG BID FOR GERD AND IBUPROFEN 800 MG TID FOR PAIN/INFLAMMATION STARTED 12/11 (11:15 AM): PT STATES HA WORSENED AND BUMPY RASH ALL OVER BODY LABS NORMAL
High fever 3 hours after giving the vaccination. Went up to 104.6F. Also crying and fussiness. Child was referred to hospital.
approx 1 day after vaccine administered, child developed pain, redness, swelling at injection site (arm). Swelling extended from deltoid, to mid arm. Patient seen in area ER and was told had "infection" at site, child seen in our office 2d after vaccine given and showed one of edema, induration, redness of about 3x6 cm. Child was afebrile and acted well, but complained of itching, pain at vaccine injection site.
This case was reported by a consumer via social media interactive digital media and described the occurrence of vaccination failure in a adult patient who received DTPa vaccine for prophylaxis. On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), whooping cough (serious criteria GSK medically significant), cold and sickness. On an unknown date, the outcome of the vaccination failure, whooping cough, cold and sickness were unknown. It was unknown if the reporter considered the vaccination failure, whooping cough, cold and sickness to be related to DTPa vaccine. Additional details were provided as follows: The age at the vaccination was not reported. The reporter reported she had the whooping cough vaccination when she was a child and had whooping cough as an adult. The physician said it was just a cold not to come in or worry. She was extremely sick and probably should have been in the hospital. This case was considered as suspected vaccination failure as a primary vaccination schedule, TTO (time to onset) of event whooping cough and laboratory confirmation test were not reported.
This spontaneous report was received from employee via healthcare worker refers to a 6 week old patient. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant therapy was unknown. On an unknown date the patient was vaccinated with PEDVAXHIB injection (dose, units and frequency were unknown) (lot number and expiration date unknown) for prophylaxis. In the prescribing information it was reported that it was not recommended under 2 months. The outcome of event drug administered to patient of inappropriate age was unknown. The causal relationship between the event drug administered to patient of inappropriate age and PEDVAXHIB was not provided by the reporter. There was no product quality compliant reported.
Information has been received from a nurse practitioner concerning a 17 year old female who on 15-FEB-2008 was vaccinated with her second dose of GARDASIL (lot #659653/1448U).  On 22-FEB-2008 the patient experienced 1.5 to 2 cm "firm mass" at the injection site.  The patient sought unspecified medical attention by contacting nurse.  It was reported that the patient was treated with an antibiotic (unspecified).  At the time of this report the outcome was unknown.  No other information was provided.
pt recv vax & devel erythema, swelling & tenderness @ site of inj;mild fever;
LOST OF CONSCIOUSNESS WITHIN MINUTES OF VACCINATION; SWEATING; HIGH BP 214/157 WITH "LO" PULSE; REMAINED BREATHING THE ENTIRE TIME WHILE WAITING FOR 911; GIVEN COLD COMPRESS TO THE NECK; REGAINED CONSCIOUSNESS BEFORE EMT'S ARRIVE AND COHERENT
In September I did not recognized painful spots on forehead which got progressively worse by 9/3. Could trace nerve across all face (nose, forehead, ear, eye). Felt pain like broken light bulb pressing into scalp. Based on symptoms nurse prescribe VALTRAX (7-9 day) treatment. No pustules or eruptions but did have pain. Light rash on forehead and face largely dissipated by end of treatment. In 1 month or less came and dissipated. By end of September diagnosed with PHN (postherpetic neuralgla) and still have it. Prescribed gabapentin 600mg 3 times/day. Nerve pain worst at times than others. Flares in pain(burning/throbbing/sharp shooting aching pain) by right eyebrow. Intense itching were nerve circles around. Temperature changes cause it to get worse; manage pain with ice packs.
Starting the next day, I had an increased sensitivity to motion sickness.  This is unusual as I am a paramedic and work in an ambulance for a living.  I also suffered 2 nights of insomnia.  On the evening of the third day, I developed joint aches, fatigue, and a series of normal bowel movements (five in 2 hours). The next morning I added a lost of balance and a slight right side facial droop around my eye (no numbness). Later that day I developed nausea and vomiting, a single period of cold chills followed by a period of a hot flash.  However, I never developed a fever.  By day five, all of my symptoms resolved with the balance issue being the last.  Also of note, early on, my blood sugar was elevated, blood pressure was elevated, and pulse elevated.
I got a rash/hive on my right leg the night I got my shot. I thought it was a bug bite but it?s not getting better, the rash is spreading and getting more hives and bigger. It itches a lot
Information has been received from a 68 year old male patient referring to himself. The patient had no pertinent medical history or drug reactions/allergies. Between 15 to 18 years ago, on an unknown date, the patient was vaccinated with a dose of unspecified pneumococcal vaccine (manufacture unknown) (lot#, strength, dose, route and expiry date were not provided). Concomitant therapies included LIPITOR. The patient experienced a mild reaction to the unspecified pneumococcal vaccine (manufacture unknown). The patient reported that he experienced redness, warmth around the injection site, and swelling within six hours of administration of the pneumococcal vaccine (manufacture unknown). Within the next two days the adverse effects dissipated and he recovered on an unknown date. The patient didn't seek for medical attention. No treatment was given for the adverse events. No lab diagnostics study was performed. Additional information has been requested.
REDNESS, SWELLING, HOT TO TOUCH. Cephalexin 500 mg capsule take 1 capsule(s) every 6 hours by oral route for 7 days.
Per pt, within 30 minutes after shot he couldn't raise his left arm.  Pt is still experiencing this effect after 2 weeks.
Patient presented to a mobile vaccination as having not been vaccinated prior.  A single dose J & J was given. The mobile vaccination vehicle cannot access internet so could not see IRIS. Patient was non English speaking but a live interpreter was present and used.
pain in her arm; a little headache; low grade temperature; This is a spontaneous report from a contactable consumer.  A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 05Jan2021 at a single dose (2nd dose) for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took her first dose of bnt162b2 for Covid-19 immunization on an unspecified date. On 05Jan2021, yesterday,  the patient received her 2nd dose of the vaccine. She has pain in her arm, a little headache and low grade temperature on an unspecified date in Jan2021. The patient was asking if there is any contra-indication with acetaminophen (TYLENOL). Outcome of the events was unknown.  Information about lot/batch number has been requested.
Patient presented with rash 1 month after admin of zostavax Patient declined treatment rash is resolving.